PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22021366-3 2011 We report that AMPK activators, such as metformin and 5-aminoimidazole-4-carboxamide ribonucleotide, suppress activation of the mTOR pathway in BCR-ABL-expressing cells. Metformin 40-49 ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens 144-151